ACASTI PHARMA INC's ticker is and the CUSIP is 00430K873. A total of 14 filers reported holding ACASTI PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,931 | +14.2% | 11,295 | 0.0% | 0.00% | – |
Q1 2023 | $5,195 | -8.2% | 11,295 | 0.0% | 0.00% | – |
Q4 2022 | $5,659 | -5.7% | 11,295 | 0.0% | 0.00% | – |
Q3 2022 | $6,000 | -62.5% | 11,295 | -39.5% | 0.00% | – |
Q2 2022 | $16,000 | -75.8% | 18,664 | -65.7% | 0.00% | – |
Q1 2022 | $66,000 | +57.1% | 54,464 | +63.4% | 0.00% | – |
Q4 2021 | $42,000 | +44.8% | 33,331 | +126.0% | 0.00% | – |
Q3 2021 | $29,000 | – | 14,749 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|